Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help patients with type 2 diabetes manage blood sugar.

Ozempic and similar drugs are advertised all over the place, from television ads, public transit, audio streaming platforms and of course social media. Ozempic is a brand name semaglutide, a medication used to treat type 2 diabetes.

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons have been repeatedly warned about the dangers of using these medications without a doctor’s supervision following serious complications experienced by some patients.

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts weigh the pros and cons of the practice.

Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss. GLP-1 medications were originally intended to treat type 2 diabetes, but a growing number of people are using it for weight loss.

Research reveals groundbreaking results about Mounjaro and Ozempic in weight loss treatment. Here's what you need to know about these game-changing medications.